studiedDrug

URI: https://gptkb.org/prop/studiedDrug
47 triples
GPTKB property
Alternative names (1)
testedDrug
Random triples
Subject Object
gptkb:ECHO-301/KEYNOTE-252_trial gptkb:pembrolizumab
gptkb:COVID-19_Solidarity_Trial_(WHO) gptkb:interferon_beta-1a
gptkb:Solidarity_trial_(WHO) gptkb:lopinavir/ritonavir
gptkb:Solidarity_trial_(WHO) hydroxychloroquine
gptkb:SURPASS-2 gptkb:tirzepatide
gptkb:REDUCE-IT gptkb:icosapent_ethyl
gptkb:ECHO-301/KEYNOTE-252_trial gptkb:epacadostat
gptkb:PACIFIC_trial gptkb:durvalumab
gptkb:CheckMate_227 gptkb:ipilimumab
gptkb:Oxygent_Clinical_Trials Oxygent
gptkb:CALM_trial gptkb:adalimumab
gptkb:ACTT-1 gptkb:remdesivir
gptkb:COVID-19_Solidarity_Trial_(WHO) gptkb:lopinavir/ritonavir
gptkb:Solidarity_trial gptkb:interferon_beta-1a
gptkb:Adaptive_COVID-19_Treatment_Trial_1 gptkb:remdesivir
gptkb:IMpower150 gptkb:carboplatin
gptkb:IMpower150 paclitaxel
gptkb:FOURIER_trial gptkb:evolocumab
gptkb:Rivaroxaban_Once_Daily_Oral_Direct_Factor_Xa_Inhibition_Compared_with_Vitamin_K_Antagonism_for_Prevention_of_Stroke_and_Embolism_Trial_in_Atrial_Fibrillation gptkb:rivaroxaban
gptkb:ACTT-1 placebo
Please wait…